Rob Riemsma
-
- Pain Management and Opioid Use 4
- Applied Psychology top 5%
- Rheumatology top 5%
- Rheumatoid Arthritis Research and Therapies 8
- Spondyloarthritis Studies and Treatments 5
- Hematology top 10%
- Autoimmune and Inflammatory Disorders Research 5
- Pharmacology top 5%
-
- Psoriasis: Treatment and Pathogenesis 5
-
- Lymphoma Diagnosis and Treatment 5
-
- Health Systems, Economic Evaluations, Quality of Life 4
-
- Pain Mechanisms and Treatments 4
- Co-authors
- Jos KleijnenKate MissoKate LightNerys WoolacottLisa MatherZarnie KhadjesariGill WorthyNigel Armstrong
- Journals
- PharmacoEconomics (13 papers)Health Technology Assessment (10 papers)Current Medical Research and Opinion (3 papers)
- Partner nations
- United KingdomNetherlandsUnited States
In The Last Decade
Rob Riemsma
51 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 134
- Anesthesiology and Pain Medicine 120
- Applied Psychology 104
- Rheumatology 287
- Hematology 150
- Pharmacology 210
Countries citing papers authored by Rob Riemsma
This map shows the geographic impact of Rob Riemsma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob Riemsma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob Riemsma more than expected).
Fields of papers citing papers by Rob Riemsma
This network shows the impact of papers produced by Rob Riemsma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob Riemsma. The network helps show where Rob Riemsma may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rob Riemsma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 12 | |
| 2 | 2019 | 8 | |
| 3 | 2018 | 10 | |
| 4 | 2018 | 3 | |
| 5 | 2018 | 11 | |
| 6 | 2018 | 11 | |
| 7 | 2017 | 25 | |
| 8 | 2017 | 64 | |
| 9 | 2015 | 2 | |
| 10 | 2013 | 39 | |
| 11 | 2011 | 67 | |
| 12 | 2009 | 42 | |
| 13 | 2009 | 17 | |
| 14 | 2007 | 49 | |
| 15 | 2006 | 200 | |
| 16 | 2006 | 18 | |
| 17 | 2006 | 90 | |
| 18 | 2005 | 57 | |
| 19 | 2003 | 168 | |
| 20 | 1998 | 120 |
About Rob Riemsma
Rob Riemsma is a scholar working on Hematology, Rheumatology and Anesthesiology and Pain Medicine, having authored 51 papers that have together received 1.8k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (8 papers), Spondyloarthritis Studies and Treatments (5 papers), Autoimmune and Inflammatory Disorders Research (5 papers), Psoriasis: Treatment and Pathogenesis (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Pain Management and Opioid Use (4 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Pain Mechanisms and Treatments (4 papers). The work is most often cited by research in Anesthesiology and Pain Medicine (120 citations), Applied Psychology (104 citations) and Rheumatology (287 citations). Rob Riemsma has collaborated with scholars based in United Kingdom, Netherlands and United States. Frequent co-authors include Jos Kleijnen, Kate Misso, Kate Light, Nerys Woolacott, Lisa Mather, Zarnie Khadjesari, Gill Worthy, Nigel Armstrong, Mark Sculpher and Yolanda Bravo Vergel. Their work appears in journals such as PharmacoEconomics, Health Technology Assessment, Current Medical Research and Opinion, British Journal of Cancer and Current Opinion in Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.